Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus - PubMed (original) (raw)
. 2009 Nov 13;33(8):1425-30.
doi: 10.1016/j.pnpbp.2009.07.021. Epub 2009 Jul 24.
Affiliations
- PMID: 19632287
- DOI: 10.1016/j.pnpbp.2009.07.021
Free article
Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
Jucélia J Fortunato et al. Prog Neuropsychopharmacol Biol Psychiatry. 2009.
Free article
Abstract
Harmine is a beta-carboline alkaloid that inhibits monoamine reuptake systems. Findings point to an antidepressant effect of the compounds that increases the levels of monoamines after monoamine oxidase inhibition. The present study aims to compare the behavioral effects and the BDNF hippocampus levels of acute administration of harmine and imipramine in rats. To this aim, rats were acutely treated with harmine (5, 10 and 15 mg/kg) and imipramine (10, 20 and 30 mg/kg) and animal behavior was assessed in the forced swimming and open-field tests. Afterwards, hippocampal BDNF protein levels were assessed in imipramine- and harmine-treated rats by ELISA-sandwich assay. We observed that harmine at doses of 10 and 15 mg/kg, and imipramine at 20 and 30 mg/kg reduced immobility time, and increased both climbing and swimming time of rats compared to saline group, without affecting locomotor activity. Acute administration of harmine at the higher dose, but not imipramine, increased BDNF protein levels in the rat hippocampus. Finally, these findings further support the hypothesis that harmine could be a new pharmacological target for the treatment of mood disorders.
Similar articles
- Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus.
Garcia LS, Comim CM, Valvassori SS, Réus GZ, Barbosa LM, Andreazza AC, Stertz L, Fries GR, Gavioli EC, Kapczinski F, Quevedo J. Garcia LS, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):140-4. doi: 10.1016/j.pnpbp.2007.07.027. Epub 2007 Aug 8. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 17884272 - Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels.
Garcia LS, Comim CM, Valvassori SS, Réus GZ, Andreazza AC, Stertz L, Fries GR, Gavioli EC, Kapczinski F, Quevedo J. Garcia LS, et al. Basic Clin Pharmacol Toxicol. 2008 Dec;103(6):502-6. doi: 10.1111/j.1742-7843.2008.00210.x. Basic Clin Pharmacol Toxicol. 2008. PMID: 19067677 - Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?
Réus GZ, Stringari RB, Kirsch TR, Fries GR, Kapczinski F, Roesler R, Quevedo J. Réus GZ, et al. Brain Res Bull. 2010 Apr 5;81(6):585-9. doi: 10.1016/j.brainresbull.2009.11.013. Epub 2009 Nov 30. Brain Res Bull. 2010. PMID: 19954760 - Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM. Deltheil T, et al. Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Neuropharmacology. 2008. PMID: 18761360 Review. - Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies.
Dos Santos RG, Hallak JE. Dos Santos RG, et al. J Psychoactive Drugs. 2017 Jan-Mar;49(1):1-10. doi: 10.1080/02791072.2016.1260189. Epub 2016 Dec 5. J Psychoactive Drugs. 2017. PMID: 27918874 Review.
Cited by
- Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.
Egger K, Aicher HD, Cumming P, Scheidegger M. Egger K, et al. Cell Mol Life Sci. 2024 Sep 10;81(1):395. doi: 10.1007/s00018-024-05353-6. Cell Mol Life Sci. 2024. PMID: 39254764 Free PMC article. Review. - Insights into free radicals scavenging, α-Amylase inhibition, cytotoxic and antifibrotic activities unveiled by Peganum harmala extracts.
Jaradat N, Hawash M, Sharifi-Rad M, Shakhshir A, Sobuh S, Hussein F, Issa L, Hamamrhe S, Al-Sheikh E, Ibrahim AN. Jaradat N, et al. BMC Complement Med Ther. 2024 Aug 12;24(1):299. doi: 10.1186/s12906-024-04602-2. BMC Complement Med Ther. 2024. PMID: 39135016 Free PMC article. - Ayahuasca: A review of historical, pharmacological, and therapeutic aspects.
Ruffell SGD, Crosland-Wood M, Palmer R, Netzband N, Tsang W, Weiss B, Gandy S, Cowley-Court T, Halman A, McHerron D, Jong A, Kennedy T, White E, Perkins D, Terhune DB, Sarris J. Ruffell SGD, et al. PCN Rep. 2023 Oct 2;2(4):e146. doi: 10.1002/pcn5.146. eCollection 2023 Dec. PCN Rep. 2023. PMID: 38868739 Free PMC article. Review. - Effects of small molecules on neurogenesis: Neuronal proliferation and differentiation.
Jastrzębski MK, Wójcik P, Stępnicki P, Kaczor AA. Jastrzębski MK, et al. Acta Pharm Sin B. 2024 Jan;14(1):20-37. doi: 10.1016/j.apsb.2023.10.007. Epub 2023 Oct 20. Acta Pharm Sin B. 2024. PMID: 38239239 Free PMC article. Review. - Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential.
Allen J, Dames SS, Foldi CJ, Shultz SR. Allen J, et al. Mol Psychiatry. 2024 Mar;29(3):671-685. doi: 10.1038/s41380-023-02360-0. Epub 2024 Jan 4. Mol Psychiatry. 2024. PMID: 38177350 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical